ClinicalTrials.gg
CompletedNCT07876388Updated Oct 15, 2026

Compassion-Based Rehabilitation Needs Assessment Following Colorectal Cancer Surgery

An interventional study of Compassionate Access Targeted Therapy in Colonrectal Cancer and Colonrectal Cancer (CRC), sponsored by Esbjerg Hospital - University Hospital of Southern Denmark. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Esbjerg Hospital - University Hospital of Southern Denmark · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 2 years 11 months after the study started (first participant enrolled Oct 2023, registered Oct 2026).
Updated Oct 15, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
77
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This randomized controlled trial evaluated the effect of a compassion-based intervention compared with standard procedure for rehabilitation needs assessment among patients undergoing surgery for colorectal cancer with curative intent.

Participants were randomly assigned to either a structured, compassion-supported rehabilitation needs assessment or standard postoperative care. The intervention focused on identifying physical, psychological, and social rehabilitation needs through compassionate communication and facilitating referral to municipal cancer rehabilitation services.

The primary outcome was health-related quality of life measured using the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) at three months. Secondary outcomes included anxiety, depression, self-compassion, and participation in cancer rehabilitation.

02

Conditions studied

  • Colonrectal Cancer
  • Colonrectal Cancer (CRC)

Keywords

  • colonrectal cancer
  • compassion
  • randomized controlled trial
  • Patient-centered care
  • Cancer rehabilitation
  • Needs assessment
03

In context

Lead sponsor

Esbjerg Hospital - University Hospital of Southern Denmark is the lead sponsor of 50 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

Inclusion Criteria:

Adults aged 18 years or older.

Patients undergoing surgery with curative intent for colorectal cancer (colon or rectal cancer).

Able to speak and understand Danish.

Exclusion Criteria:

Patients younger than 18 years.

Patients unable to speak or understand Danish.

Patients not undergoing surgery with curative intent for colorectal cancer.

-

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
77 participants (actual)

Study arms

  • No intervention
    Standard Procedure

    Participants allocated to the control group received standard postoperative care following colorectal cancer surgery. Approximately two weeks after surgery, patients attended an outpatient follow-up consultation with a physician and a colorectal nurse. Subsequently, a nurse from the outpatient clinic conducted a telephone follow-up during which rehabilitation needs could be assessed using the standard needs assessment checklist. Patients with identified rehabilitation needs could be referred to municipal cancer rehabilitation services according to routine clinical procedures. No additional compassion-supported consultation was provided.

  • Experimental
    Compassion intervention

    Participants allocated to the intervention group received standard postoperative care followed by an additional structured, compassion-supported rehabilitation needs assessment approximately seven days after the standard postoperative follow-up. The intervention consisted of an approximately 30-minute face-to-face consultation conducted by a registered nurse trained in compassion-based approaches. The consultation focused on identifying physical, psychological, and social rehabilitation needs through compassionate communication, attentive listening, and non-judgmental dialogue. Identified needs were discussed with the patient, and referral to municipal cancer rehabilitation services was facilitated through shared decision-making when appropriate.

    Behavioral: Compassionate Access Targeted Therapy

Interventions

  • BehavioralCompassionate Access Targeted Therapy

    The intervention consisted of a structured, compassion-supported rehabilitation needs assessment delivered during an approximately 30-minute face-to-face consultation with a registered nurse trained in compassion-based approaches. The consultation took place approximately seven days after the standard postoperative follow-up visit. The intervention incorporated three components: (1) systematic identification of physical, psychological, and social rehabilitation needs using the standard needs assessment framework; (2) compassion-supported communication characterized by attentive listening, presence, openness, non-judgment, and sensitivity to patients' concerns; and (3) shared decision-making regarding referral to municipal cancer rehabilitation services. When rehabilitation needs were identified and the patient agreed, referral to municipal cancer rehabilitation was facilitated according to standard hospital procedures.

06

What researchers measure

Primary outcomes

  1. Health-Related Quality of Life Measured by FACT-C Total Score

    Health-related quality of life will be assessed using the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) questionnaire. The FACT-C measures physical, social, emotional, and functional well-being, as well as colorectal cancer-specific concerns. The total score ranges from 0 to 136, with higher scores indicating better health-related quality of life. The primary outcome is the between-group difference in FACT-C total score at the three-month follow-up.

    Time frame: 3 months after the intervention

Secondary outcomes

  1. Anxiety Severity Measured by m-ESAS

    Anxiety will be assessed using the anxiety item from the Modified Edmonton Symptom Assessment System (m-ESAS). Scores range from 0 to 10, with higher scores indicating greater anxiety severity. Scores will be compared between the intervention and standard procedure groups.

    Time frame: Baseline, 1 month, and 3 months

  2. Depression Severity Measured by m-ESAS

    Depression will be assessed using the depression item from the Modified Edmonton Symptom Assessment System (m-ESAS). Scores range from 0 to 10, with higher scores indicating greater depression severity. Scores will be compared between the intervention and standard procedure groups.

    Time frame: Baseline, 1 month, and 3 months

  3. Self-Compassion Measured by the Self-Compassion Scale (SCS-26)

    Self-compassion will be assessed using the 26-item Self-Compassion Scale (SCS-26), comprising six subscales: self-kindness, self-judgment, common humanity, isolation, mindfulness, and over-identification. Items are rated on a five-point scale from 1 to 5. A total self-compassion score is calculated after reverse scoring negatively worded items, with higher scores indicating greater self-compassion.

    Time frame: Baseline, 1 month, and 3 months

  4. Participation in Municipal Cancer Rehabilitation

    The proportion of participants who reported participation in municipal cancer rehabilitation services will be assessed at the three-month follow-up. Participation is defined as patient-reported engagement in a municipal cancer rehabilitation program during the follow-up period. The proportion of participants reporting rehabilitation participation will be compared between the two randomized groups.

    Time frame: Within 3 months after the intervention

07

Study locations

1 site
  • Esbjerg Sygehus
    Esbjerg, 6700, Denmark
08

References and documents

Individual participant data

Plan to share: No — The datasets generated and analyzed during the current study are not publicly available due to privacy and data protection regulations. Data sharing is restricted by applicable Danish data protection legislation and institutional requirements.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07876388
Lead sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Responsible party
Sponsor
First posted
Oct 15, 2026
Start date
Oct 10, 2023
Primary completion
Jan 4, 2026
Completion
Jan 4, 2026
Last update
Oct 15, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion